logo
Plus   Neg
Share
Email

Constellation Brands To Invest Additional $4 Bln In Canopy Growth

constellationbrands-081518-lt.jpg

Brewer Constellation Brands Inc (STZ,STZ-B) will invest C$5 billion, or $4 billion, in Canadian cannabis company Canopy Growth Corp. (CGC) as part of an expansion of the two companies' strategic partnership, the companies said Wednesday. Shares of Canopy Growth are gaining more than 27 percent in the regular trading.

"Through this investment, we are selecting Canopy Growth as our exclusive global cannabis partner. Over the past year, we've come to better understand the cannabis market, the tremendous growth opportunity it presents, and Canopy's market-leading capabilities in this space," said Rob Sands, Chief Executive Officer of Constellation Brands.

Canopy Growth is Canada's largest medical marijuana producer. The company operates ten cannabis production sites with over 2.4 million square feet of production capacity, including over 500,000 square feet of GMP-certified production space.

Constellation Brands, which acquired a 9.9 percent stake in Canopy Growth in October 2017, will increase its ownership interest in the company by acquiring 104.5 million shares directly from Canopy Growth.

Constellation will thus achieve 38 percent ownership when assuming exercise of the existing Constellation warrants. The company will buy the new shares at C$48.60 per share, representing a 51.2 percent premium to Tuesday's closing price of C$32.15.

Constellation will also receive additional warrants of Canopy that if exercised would provide for at least an additional C$4.5 billion to Canopy Growth. In addition, Constellation will nominate four directors to Canopy Growth's seven-member board of directors.

According to Constellation, the investment will provide funds that Canopy Growth can deploy to strategically build or acquire key assets required to establish global scale in the nearly 30 countries pursuing a federally permissible medical cannabis program.

The transaction requires Canopy shareholder approval and is expected to close by the end of October 2018.

The alcohol industry is betting big on the consumable cannabis market. Molson Coors Brewing Co. (TAP, TAP-A, TPX.TO) said in early August that it will form a joint venture with Canadian cannabis producer Hydropothecary Corp. or HEXO (HEXO.TO) to develop non-alcoholic, marijuana-infused beverages for the Canadian market following legalization.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT